Literature DB >> 30916595

Developing a disease management program for the improvement of heart failure outcomes: the do's and the don'ts.

Liam Healy1, Mark Ledwidge1, Joe Gallagher2, Chris Watson1, Kenneth McDonald1.   

Abstract

INTRODUCTION: Heart failure is a highly prevalent condition affecting approximately 2% of people worldwide. Heart failure disease management programs (DMP) have shown a reduction in mortality and reduced hospitalization and are an established part of clinical guidelines; however, their presence is not widespread. Focusing on the application of proven therapies, patient education, diagnosis with work up of cause and easy access for clinical deterioration should be fundamental to the structure of the DMP. Multidisciplinary team care with early and timely recognition of potentially critical patients is essential, along with the inclusion of patients diagnosed in hospital as well as the community. Areas covered: The fundamental structure of a DMP along with the current gaps in evidence is outlined. Current challenges with the heart failure condition along with the current best evidence are covered. Articles were searched using MEDLINE containing the keywords; Chronic Heart Failure, Disease Management Program. We have also provided clinical opinion. Expert opinion: A multidisciplinary approach to disease management programs is essential to providing adequate care to patients. DMPs are an established part of current guidelines and should be a benchmark of treatment. Future resources should be focused on identifying patients at risk and early prevention.

Entities:  

Keywords:  Chronic heart failure; disease management program; heart failure/diagnosis; heart failure/therapy; patient-centred care

Mesh:

Year:  2019        PMID: 30916595     DOI: 10.1080/14779072.2019.1596798

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  1 in total

1.  Attitudes to and experience of disease management programs in primary care-an exploratory survey of general practitioners in Germany.

Authors:  Julian Wangler; Michael Jansky
Journal:  Wien Med Wochenschr       Date:  2021-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.